International trade · 25/03/2010Updated: 10/17/2026 · 1 min read
Eli Lilly to Waive Patent Restrictions on COVID-19 Treatment for Algeria
Summary
Eli Lilly has agreed to waive patent restrictions on its COVID-19 treatment, baricitinib, to provide it to the Central Government of Algeria, following a request from the US government to support the country's efforts to combat the pandemic.